Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 5/20 | 0.77 |
| ▸ | USP2 | O75604 | 3/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.77 |
| ▸ | RECQL | P46063 | 2/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | EGFR | P00533 | 1/20 | 0.77 |
| ▸ | LCK | P06239 | 1/20 | 0.77 |
| ▸ | FYN | P06241 | 1/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.77 |
| ▸ | HTR2A | P28223 | 1/20 | 0.77 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.77 |
| ▸ | PKM | P14618 | 3/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508389 | 1.00 | SLC7A5 (0.77) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL2767910 | 1.00 | SLC7A5 (0.77) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL29364864 | 0.94 | SLC7A5 (0.69) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL9924695 | 0.94 | SLC7A5 (0.69) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| SCHEMBL13588692 | 0.91 | SLC7A5 (0.65) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Levodopa SCHEMBL22655 | 0.87 | SLC7A5 (1.00) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Levodopa SCHEMBL704089 | 0.87 | SLC7A5 (1.00) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Levodopa SCHEMBL29975814 | 0.87 | SLC7A5 (1.00) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Levodopa SCHEMBL20582239 | 0.87 | SLC7A5 (1.00) | SLC7A5USP2PTGS1KDM4EALOX15 | |
| Levodopa SCHEMBL11000382 | 0.87 | SLC7A5 (1.00) | SLC7A5USP2PTGS1KDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3470 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4623143-A1 | METHOD FOR PRODUCING REINFORCED TEXTILE FIBER COMPOSITIONS | LigaMore ApS (DK) | 2025-10-01 | — | — | EP | claimed |
| CN-119529036-A | Conformationally stabilized RSV pre-fusion F proteins | 考尔德生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119351394-A | Method for immobilizing beta-mannase and beta-xylanase by utilizing yeast spores, application and product thereof | 中国食品发酵工业研究院有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118986895-A | Virus-like ruthenium oxide nano-particles for high-efficiency transmembrane treatment of keratoconus by visible light catalytic crosslinking | 山东第一医科大学附属眼科医院(山东省眼科医院) | 2024-11-22 | — | — | CN | claimed |
| CN-118976121-A | Preparation and application methods of viroid cation-like ruthenium-based nanoparticle | 山东第一医科大学附属眼科医院(山东省眼科医院) | 2024-11-19 | — | — | CN | claimed |
| WO-2024158919-A2 | SILK BIOPLASTICS AND METHOD OF MAKING SAME | TRUSTEES OF TUFTS COLLEGE (US) | 2024-08-02 | — | — | WO | claimed |
| US-12044684-B2 | Methods for diagnosing an autistic spectrum disorder | QATAR UNIVERSITY (QA) | 2024-07-23 | — | — | US | claimed |
| US-20240238369-A1 | Conformationally Specific Viral Immunogens | CALDER BIOSCIENCES INC (US) | 2024-07-18 | — | — | US | claimed |
| WO-2024144269-A1 | BIOINK COMPRISING FUNCTIONAL PEPTIDE | 한국재료연구원 | 2024-07-04 | — | — | WO | claimed |
| EP-4376846-A1 | BIOACTIVE COMPOSITIONS AND METHODS OF USE THEREOF | PX ING, LLC (US) | 2024-06-05 | — | — | EP | claimed |
| US-20030180218-A1 | Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents | THE CLEVELAND CLINIC FOUNDATION | 2003-09-25 | — | — | US | claimed |
| EP-1296705-A1 | NEUROTOXIC OLIGOMERS | Prana Biotechnology Ltd (AU) | 2003-04-02 | — | — | EP | claimed |
| US-6541265-B2 | Applying exercise stimulants; induce muscle injuries; measurement inflammation; calibration | UNIVERSITY OF FLORIDA | 2003-04-01 | — | — | US | claimed |
| US-20030044878-A1 | Method and system to test a substance for inflammatory or oxidant properties | FLORIDA, UNIVERSITY OF | 2003-03-06 | — | — | US | claimed |
| WO-2002090977-A1 | METHOD AND SYSTEM TO TEST A SUBSTANCE FOR INFLAMMATORY OR OXIDANT PROPERTIES | UNIVERSITY OF FLORIDA (US) | 2002-11-14 | — | — | WO | claimed |
| US-20020164662-A1 | Myeloperoxidase, a risk indicator for cardiovascular disease | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-11-07 | — | — | US | claimed |
| EP-1251730-A1 | PREPARATION AND USE OF POLYMERS CROSSLINKED WITH TYROSINE-CONTAINING PEPTIDES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2002-10-30 | — | — | EP | claimed |
| WO-2002062207-A2 | MYELOPEROXIDASE, A RISK INDICATOR FOR CARDIOVASCULAR DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2002-08-15 | — | — | WO | claimed |
| WO-2002000245-A1 | NEUROTOXIC OLIGOMERS | PRANA BIOTECHNOLOGY LIMITED (AU) | 2002-01-03 | — | — | WO | claimed |
| WO-2001054486-A1 | PREPARATION AND USE OF POLYMERS CROSSLINKED WITH TYROSINE-CONTAINING PEPTIDES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2001-08-02 | — | — | WO | claimed |